Neurologian yksikkö
Department of Neurology

Julkaisut 2007
Publications 2007

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Cavalleri GL et al. Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case control-study.
2 Wegiel J et al. Intraneuronal AB immunoreactivity is not a predictor of brain amyloidosis-B or neurofibrillary degeneration.
3 Ahtoniemi T et al. Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis.
4 Airas L et al. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells.
5 Buerger K et al. No correlation between CSF tau protein phosphorylated at threonine 181 with neocortical neurofibrillary pathology in Alzheimer's disease.
6 Clarke J et al. Overexpression of APP provides neuroprotection in the absence of functional benefit following middle cerebral artery occlusion in rats.
7 Diamond EL et al. Relationship of fMRI activation to clinical trial memory measures in Alzheimer disease.
8 Haapasalo A et al. Presenilin/gamma-secretase-mediated cleavage regulates association of leukocyte-common antigen-related (LAR) receptor tyrosine phosphatase with beta-catenin.
9 Helisalmi S. Lipid profile factors and apolipoprotein E polymorphism in Alzheimer´s disease.
10 Herrgård E et al. More severe epilepsy and cognitive impairment in the offspring of a mother with mosaicism for the ring 20 chromosome.
11 Herukka S-K et al. CSF Abeta42, tau and phosphorylated tau, APOE epsilon4 allele and MCI type in progressive MCI.
12 Herukka SK. Usefulness of Cerebrospinal Fluid Biomarkers in Diagnosis of Early Alzheimer's Disease.
13 Hicks AU et al. Enriched environment enhances transplanted subventricular zone stem cell migration and functional recovery after stroke.
14 Hooijmans CR et al. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice.
15 Hooijmans CR et al. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
16 Huhtala A et al. In vitro biocompatibility of degradable biopolymers in cell line cultures from various ocular tissues:Direct contact studies.
17 Huuskonen J. Microglial Response to Inflammatory Stimuli-Impact of Protein Acetylation and Phosphorylation.
18 Hämäläinen A et al. Increased fMRI responses during encoding in mild cognitive impairment.
19 Hämäläinen A et al. Voxel-based morphometry to detect brain atrophy in progressive mild cognitive impairment.
20 Jolkkonen J et al. Subacute hemorrhage and resolution of edema in Rose Bengal stroke model in rats coincides with improved sensorimotor functions.
21 Jolkkonen J, van Groen T. Thalamic calcification and amyloid deposition following focal cerebral ischemia in rats.
22 Joyal CC et al. Violent persons with schizophrenia and comorbid disorders: a functional magnetic resonance imaging study.
23 Juva K et al. Blood pressure and survival in the very old.
24 Kalesnykas G et al. The expression of heat shock protein 27 in retinal ganglion and glial cells in a rat glaucoma model.
25 Karhunen H. Long-Term Studies of Epileptogenesis After Focal Cerebral Ischemia in Rats.
26 Karhunen H et al. Epileptogenesis after cortical photothrombotic brain lesion in rats.
27 Kiviranta PH et al. N-(3-(4-hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors.
28 Komulainen P et al. Carotid intima-media thickness and cognitive function in elderly women: a population-based study.
29 Komulainen P et al. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women.
30 Komulainen P et al. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
31 Koponen A et al. Social functioning and psychological well-being of 347 young adults with epilpsy only-population-based, controlled study from Finland.
32 Korolainen MA et al. Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease.
33 Kumlin T et al. Mobile phone radiation and the developing brain: behavioral and morphological effects in juvenile rats.
34 Kälviäinen R. Status epilepticus treatment guidelines.
35 Kälviäinen R et al. Juvenile-onset neuronal ceroid lipofuscinosis with infantile CNL1 mutation and palmitoyl-protein thioesterase deficiency.
36 Lamusuo S et al. Nainen ja epilepsia.
37 Lämsä R et al. Study on the association between SOAT1 polymorphisms, Alzheimer´s disease risk and the level of CSF biomarkers.
38 Lämsä R et al. The association study between DHCR24 polymorphisms and Alzheimer's disease.
39 Malm TM et al. Pyrrolidine dithiocarbamate activates akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden.
40 Myöhänen TT et al. Distribution of immunoreactive prolyl oligopeptidase in human and rat brain.
41 Mönkkönen KS et al. Intracerebroventricular antisense knockdown of G-alpha-i2 results in ciliary stasis and ventricular dilatation in the rat.
42 Narkilahti S et al. Increased expression of caspase 2 in experimental and human temporal lobe epilepsy.
43 Ngandu T et al. Alcohol drinking and cognitive functions: findings from the cardiovascular risk factors aging and dementia (CAIDE) study.
44 Ngandu T et al. Education and dementia: What lies behind the association?
45 Niskanen EI et al. Subspace approaches for fMRI time series estimation.
46 Nuutinen T et al. Amyloid-beta 1-42 induced endocytosis and clusterin/apoJ protein accumulation in cultured human astrocytes.
47 Paimela T et al. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells.
48 Parkkinen J et al. Molecular mechanisms underlying neuroprotective effects of albumin after ischemic stroke.
49 Parkkinen L et al. Abundant glial alpha-synuclein pathology in a case without overt clinical symptoms.
50 Parviainen I et al. Propofol and barbiturates for the anesthesia of refractory convulsive status epilepticus: pros and cons.
51 Peurala SH et al. Effects of intensive gait-oriented physiotherapy during early acute phase of stroke.
52 Peurala SH et al. Postural instability in patients with chronic stroke.
53 Pirttilä T et al. Kuntoutuksella keskeinen rooli dementoivaa sairautta sairastavan hoidossa.
54 Rastas S et al. Atrial fibrillation, stroke, and cognition: a longitudinal population-based study of people aged 85 and older.
55 Rovio S et al. Work-related physical activity and the risk of dementia and Alzheimer's disease.
56 Sakka P et al. Effectiveness of open-label donepezil treatment in patients with Alzheimer's disease discontinuing memantine monotherapy.
57 Schmitt A et al. How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.
58 Seppänen A et al. Distribution of collagen XVII in the humain brain.
59 Shafaati M et al. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.
60 Sillanpää M et al. Onko epilepsian ilmaantuvuus pienentynyt?
61 Soininen H et al. Long-term efficacy and safety of celecoxib in Alzheimer´s disease.
62 Solomon A et al. Serum cholesterol changes after midlife and late-life cognition. Twenty-one-year follow-up study.
63 Suuronen T et al. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells.
64 Tesco G et al. Depletion of GGA3 stabilizes bace and enhances [beta]-secretase activity.
65 Tolonen H et al. The validation of the Finnish hospital Discharge register an causes of death register data on stroke diagnoses.
66 van Groen T et al. Transient occlusion of the middle cerebral artery in rats leads to permanent amyloid deposits in the thalamus.
67 Vepsäläinen S. A Molecular Genetic Study and Expression-Based Analysis of Risk Factors of Alzheimer's Disease. Emphasis on AB-degrading Enzymes, IDE and NEP.
68 Vepsäläinen S et al. Somatostatin genetic variants modify the risk for Alzheimer´s disease among finnish patients.
69 Vepsäläinen S et al. Insulin-degrading enzyme is genetically associated wirh Alzheimer's disease in the finnish population.
70 Viinikainen K. Epilepsy, Female Reproductive Health and Neurodevelopment of the Offspring.
71 Viinikainen K et al. Fertility in women with active epilepsy.
72 Weinsheimer S et al. Integration of expression profiles and genetic mapping data to identify candidate genes in intracranial aneurysm.
Neurologian yksikkö Department of Neurology
Julkaisutietokanta 18.6.2008 Publications Data Base 18.6.2008